"PrognosDx Health, Inc. - Product Pipeline Analysis, 2013 Update" Is Now Available at Fast Market Research
PrognosDx Health, Inc. (PrognosDx) is a biotechnology company. The company develops products for the treatment of cancer and other complex diseases. Its products include PrognoScore, and RxScore. PrognosDx's PrognoScore is used in the treatment of prostate cancer and bladder cancer. The company's RxScore is a therapeutic test for pancreatic, breast, colorectal, and lung cancers. Its technology platform is based on discovery at UCLA to develop histone proteins as prognostic markers for many cancers and as drug response predictive biomarkers. The...
View full press release